NurExone Biologic (NRX.V) Q3 2024 Earnings

28AugConfirmed
Q2 2023
Q2 2024
Q3 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.026950400000000003
Actual EPS
-0.053900800000000006
Surprise EPS
-0.03
Surprise Percent
+100%

Description

NurExone Biologic (NRX.V) has reported earnings of -0.053900800000000006 per share for Q3 2024.

0 Comments

Share your thoughts